H.R. 2455
Referred to CommitteeEnsuring Timely Access to Generics Act of 2019
Latest Action
Referred to the Subcommittee on Health.
5/2/2019 • House
Summary
Ensuring Timely Access to Generics Act of 2019
This bill requires the Food and Drug Administration (FDA) to consider certain factors in determining whether a petition is submitted for the primary purpose of delaying the approval of a drug application.
The FDA must (1) publish a list of petitions that were submitted with an intent to delay, and (2) establish procedures to refer such petitions to the Federal Trade Commission.
The FDA may establish a timeline for submitting petitions.
Introduced in House • 5/1/2019
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (7)
Party Breakdown
Sponsor
Cosponsors (6)
Bill Journey
Originated in the House
Introduced
May 1, 2019
Referred to the House Committee on Energy and Commerce.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law